Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy.
J Clin Invest. 2020 Jan 2;130(1):451-465. doi: 10.1172/JCI127515.
J Clin Invest. 2020.
PMID: 31613799
Free PMC article.